| Tretinoin | Approved Investigational Nutraceutical | TENM3 | 55714 |
downregulated | Tretinoin results in decreased expression of TENM3 mRNA | 4q34.3-q35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TERT | 7015 |
downregulated | Tretinoin results in decreased expression of TERT mRNA | 5p15.33 | |
| Tretinoin | Approved Investigational Nutraceutical | TES | 26136 |
upregulated | Tretinoin results in increased expression of TES mRNA | 7q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TESC | 54997 |
downregulated | Tretinoin results in decreased expression of TESC mRNA | 12q24.22 | |
| Tretinoin | Approved Investigational Nutraceutical | TEX15 | 56154 |
downregulated | Tretinoin results in decreased expression of TEX15 mRNA | 8p12 | |
| Tretinoin | Approved Investigational Nutraceutical | TEX2 | 55852 |
upregulated | Tretinoin results in increased expression of TEX2 mRNA | 17q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TEX38 | 374973 |
upregulated | Tretinoin results in increased expression of TEX38 mRNA | 1p33 | |
| Tretinoin | Approved Investigational Nutraceutical | TEX9 | 374618 |
upregulated | Tretinoin results in increased expression of TEX9 mRNA | 15q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TFAP2A | 7020 |
upregulated | Tretinoin results in increased expression of TFAP2A mRNA | 6p24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TFAP2B | 7021 |
downregulated | Tretinoin results in decreased expression of TFAP2B mRNA | 6p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TFAP4 | 7023 |
downregulated | Tretinoin results in decreased expression of TFAP4 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TFB2M | 64216 |
downregulated | Tretinoin results in decreased expression of TFB2M mRNA | 1q44 | |
| Tretinoin | Approved Investigational Nutraceutical | TFDP1 | 7027 |
downregulated | Tretinoin results in decreased expression of TFDP1 mRNA | 13q34 | |
| Tretinoin | Approved Investigational Nutraceutical | TFDP2 | 7029 |
downregulated | Tretinoin results in decreased expression of TFDP2 mRNA | 3q23 | |
| Tretinoin | Approved Investigational Nutraceutical | TFPI | 7035 |
upregulated | Tretinoin results in increased expression of TFPI mRNA | 2q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TFPI2 | 7980 |
downregulated | Tretinoin results in decreased expression of TFPI2 mRNA | 7q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TFPI2 | 7980 |
upregulated | Tretinoin results in increased expression of TFPI2 mRNA | 7q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TFRC | 7037 |
downregulated | Tretinoin results in decreased expression of TFRC mRNA | 3q29 | |
| Tretinoin | Approved Investigational Nutraceutical | TG | 7038 |
downregulated | Tretinoin results in decreased expression of TG mRNA | 8q24.22 | |
| Tretinoin | Approved Investigational Nutraceutical | TG | 7038 |
upregulated | Tretinoin results in increased expression of TG mRNA | 8q24.22 | |
| Tretinoin | Approved Investigational Nutraceutical | TGFA | 7039 |
upregulated | Tretinoin results in increased expression of TGFA mRNA | 2p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TGFB1 | 7040 |
downregulated | Tretinoin results in decreased expression of TGFB1 mRNA | 19q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TGFB1I1 | 7041 |
upregulated | Tretinoin metabolite results in increased expression of TGFB1I1 mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TGFB1I1 | 7041 |
upregulated | Tretinoin results in increased expression of TGFB1I1 mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TGFB2 | 7042 |
upregulated | Tretinoin results in increased expression of TGFB2 mRNA | 1q41 | |